Publications by authors named "Safoa Addo"

Claim this Profile
R
Randomized phase 2 trial of pembrolizumab alone or in combination with low dose chemotherapy for patients with non-small cell lung cancer and poor performance status.
Safoa Addo, Thomas Lycan, David R Soto-Pantoja, Yu-Ting Tsai, Ericson Stoen

Lung Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma.
Rhonda L Bitting, Janet A Tooze, Michael Goodman, Donald C Vile, Jessica M Brown, Safoa Addo

Cancer Res Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysis.
Marcelo Bonomi, Tamjeed Ahmed, Safoa Addo, Mitra Kooshki, Dario Palmieri

Oncol Lett· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis